The relative abundance of the identified compounds/peaks differentiating UCML from HC and the regulation by imatinib.

All peaks areas were normalized by the stable isotope internal standard, [13C2]-myristic acid; CPU_ DB5_RIx_P: Unidentified compounds in plasma samples detected with DB-5 capillary column in GC/TOFMS, China Pharmaceutical university (CPU); RI, retention index; x, retention time index value; P, plasma sample.
*,**: statistically significant different from that in HC, p<0.05, 0.01;
†, ††: statistically significant different from that in UCML, p<0.05, 0.01;
‡, ‡‡: statistically significant different from that in SCML, p<0.05, 0.01.
§, clinic measurement results.